Andreas von Richter

Managing Director

Andreas von Richter, brings 20 years experience of venture capital and high tech engineering expertise to the team. He has been active in the European, Israeli and US venture scene since 2007 and counts two unicorns along this track record. Prior to joining LBBW VC in 2018 he was the managing director of EcoMobility ventures at Idinvest Partners focusing on mobility/transportation themes. Before that he managed the European and Israeli operations of GE’s Venture Capital arm focusing on cleantech themes. His investments include Solaredge (NASDAQ: SEDG), Emefcy (ASX:FLC) and View. He obtained a MSc. In Aerospace engineering from Delft University of Technology, an MBA from Insead and speaks four languages fluently having lived in fifteen cities so far.

Oliver Konanz

Managing Director

Oliver Konanz has over 30 years experience in corporate financing and within the VC/PE field.  He also gained direct operational experience as CFO & CRO at two companies. Since 2010 he is also part of the management team of SuedBG – the private equity arm of LBBW. He graduated from Frankfurt School Finance & Management and holds a CVA degree.

Companies: Oxid, Crealytics

Joachim Erdle

Managing Director

Joachim Erdle has over 25 years experience in Corporate, Investment Banking and Private Equity. He heads LBBW's corporate finance activities, the banks PE arm - SuedBG - and is a managing director at LBBW VC. Prior to LBBW he was a managing director at the Société Générale within corporate loans and acquisition finance.  Within corporate banking his focus is on the German Mittelstand and large corporates supporting strategic initiatives. He has a diploma (BA) from the Baden-Wuerttemberg State University.

Dr. Harald Poth

Senior Investment Manager, Life Sciences

Harald Poth is member of the managing board of LBBW VC and heads the Life Science Team. By now he gained over 19 years investment experience in that field. Recent successful exits were Ganymed Pharmaceuticals GmbH, sloning biotechnology GmbH, Proabiogen Ag and mtm diagnostics. Prior to his VC activities he headed the Life Science startup agency in Baden-Württemberg. He studied Biology at the University Hohenheim in Stuttgart, holds a PhD with distinction in Microbiology from Hohenheim and gained scientific experience at the Université de Genève, the University of Pennsylvania,  and the Biotechnology Research Centre in Braunschweig.

Companies: Acousia Therapeutics, Amcure, Biametrics Cortec, Phenex, Poly-an

Patrick Herlinger

Investment Manager, Digital Transformation

Patrick Herlinger holds a diploma in physics from the University of Stuttgart and was a researcher for six years at the Max Planck Institute for Solid State Research in Stuttgart before joining the LBBW VC team. He obtained a broad knowledge of semiconductor processing technology, sensors, and electronics. His interests also encompass smart devices and algorithms. During his last two years of study he supported the Robert Bosch VC team as a working student and gained first insights into the VC business.

Julian Hebler

Investment Manager, Digital Transformation

Julian Hebler obtained a M.Sc. in industrial engineering from the Otto-von-Guericke University. He is a technical minded blockchain and technology enthusiast, who discovered 2017 the distributed ledger technology through his research on cutting-edge governance practices and got stunned by the ability to shift entire systems. Previously he worked as an IT-Consultant for global companies and helped to develop their digital transformation strategies. As an entrepreneur within the cryptocurrency space he led the analysis practices including startup scouting, fundamental analysis and due diligence for token investments in Vienna.

Stefanie Wojciech

Investment Manager, Life Sciences

Stefanie Wojciech is part of the Life Science Team. Prior to joining LBBW VC, she gained over five years of international experience in biomedical innovation: in project management (EU-funded project), business development (public-private partnerships and in-licensing) and consulting (non-dilutive funding) in academia and industry with the Global Care Initiative consortium, at MedDay Pharmaceuticals and EY. Stefanie Wojciech obtained a PhD in Pharmacology and Molecular and Cellular Biology from Université Paris Sud X, holds a Diploma in Biochemistry from Friedrich-Schiller-Universität Jena and speaks German, English and French fluently.

Claudia Wilhelm

Admin & Marketing

Claudia Wilhelm heads our back-office operations and supports the organization of our workshops with selected start-ups, portfolio companies and corporate clients of LBBW. Before joining LBBW VC she worked at Celesio within the controlling department. She has a BA in business administration from the Baden Wuerttemberg Cooperative State University.